Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for nalidixic root_polymer_monomers_monomerSubstance_refPname in Monomer Substance Name (approximate match)

Showing 161 - 170 of 343 results

First page
Previous page
Next page
Next page

POLYGLYCERYL-10 POLYRICINOLEATE

DHM1T5XO11

Status:

Possibly Marketed Outside US

Source:

M020

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=017d9df8-d2ad-167b-e063-6294a90a8c66

First approved in 2023

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=017d9df8-d2ad-167b-e063-6294a90a8c66

Class:

POLYMER

POLYAMIDE-3 (20000 MW)

PLF06VZ9SQ

Status:

Possibly Marketed Outside US

Source:

M020

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2bc46854-fe67-782b-e063-6294a90a79af

First approved in 2023

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2bc46854-fe67-782b-e063-6294a90a79af

Class:

POLYMER

TALINEXOMER

AZC253V6FB

Status:

Possibly Marketed Outside US

Source:

M017

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42bf129c-5c84-4331-b6d0-78e3be71a985

First approved in 2023

Source:

M017

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42bf129c-5c84-4331-b6d0-78e3be71a985

Class:

POLYMER

CARBOXYMETHYLCELLULOSE SODIUM (0.9 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 130 MPA.S AT 4%)

0891BL4S3D

Status:

Possibly Marketed Outside US

Source:

M017

(2023)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6d7c4f0-89ab-0bcd-e053-6394a90af18f

First approved in 2023

Source:

M017

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6d7c4f0-89ab-0bcd-e053-6394a90af18f

Class:

POLYMER

POLYGLYCERYL-5 POLYRICINOLEATE

FT3MR7CR64

Status:

Possibly Marketed Outside US

Source:

M020

(2022)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e92364b2-b065-b2ff-e053-2a95a90a45fa

First approved in 2022

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e92364b2-b065-b2ff-e053-2a95a90a45fa

Class:

POLYMER

POLYQUATERNIUM-47 (METHACRYLAMIDOPROPYLTRIMETHYLAMMONIUM CHLORIDE-CO-METHYL ACRYLATE-CO-ACRYLIC ACID 46:8:46; 1300000 MW)

G938900MID

Status:

Possibly Marketed Outside US

Source:

Anbiser B-HA Hyaluronic Acid Nourishing by Qingdao Huinorde Biotechnology Co., LTD

(2024)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ba8f1b8-48b2-4e5d-8ecc-f6f69fcab9f6

First approved in 2022

Source:

M006

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4795cc87-c663-4702-b65d-ce85203f1258

Class:

POLYMER

HEPARAN SULFATE (PORCINE 5500 MW)

47959853R5

Status:

Possibly Marketed Outside US

Source:

M020

(2022)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aedde765-931f-430e-9fc3-d87bde2b78cd

First approved in 2022

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aedde765-931f-430e-9fc3-d87bde2b78cd

Class:

POLYMER

DILINOLEIC ACID/BUTANEDIOL COPOLYMER

1F2S8T535O

Status:

Possibly Marketed Outside US

Source:

M020

(2021)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18e4c50d-eb91-c269-e063-6394a90a7999

First approved in 2021

Source:

M020

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18e4c50d-eb91-c269-e063-6394a90a7999

Class:

POLYMER

PEG-55 PROPYLENE GLYCOL OLEATE

7RDE7PJS40

Status:

Possibly Marketed Outside US

Source:

Strengthening Basil Root by Topiderm, Inc

(2021)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80f91ed8-4f29-4a16-b2e5-fd74a11b6a61

First approved in 2021

Source:

Strengthening Basil Root by Topiderm, Inc

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80f91ed8-4f29-4a16-b2e5-fd74a11b6a61

Class:

POLYMER

POLYGLYCERYL-6 RICINOLEATE

8X57R183N7

Status:

Possibly Marketed Outside US

Source:

Practical Alchemy Purifying by Over Here, LLC

(2025)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=28514e58-59a6-094a-e063-6394a90a1c7d

First approved in 2021

Source:

M006

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d281101b-4d07-4e71-9c73-80bdbb0b96a5

Class:

POLYMER

Structure of POLYGLYCERYL-10 POLYRICINOLEATE

Polymer

POLYGLYCERYL-10 POLYRICINOLEATE

Structure of POLYAMIDE-3 (20000 MW)

Polymer

POLYAMIDE-3 (20000 MW)

Structure of TALINEXOMER

Polymer

Structure of CARBOXYMETHYLCELLULOSE SODIUM (0.9 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 130 MPA.S AT 4%)

Polymer

CARBOXYMETHYLCELLULOSE SODIUM (0.9 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 130 MPA.S AT 4%)

Structure of POLYGLYCERYL-5 POLYRICINOLEATE

Polymer

POLYGLYCERYL-5 POLYRICINOLEATE

Structure of POLYQUATERNIUM-47 (METHACRYLAMIDOPROPYLTRIMETHYLAMMONIUM CHLORIDE-CO-METHYL ACRYLATE-CO-ACRYLIC ACID 46:8:46; 1300000 MW)

Polymer

POLYQUATERNIUM-47 (METHACRYLAMIDOPROPYLTRIMETHYLAMMONIUM CHLORIDE-CO-METHYL ACRYLATE-CO-ACRYLIC ACID 46:8:46; 1300000 MW)

Structure of HEPARAN SULFATE (PORCINE 5500 MW)

Polymer

HEPARAN SULFATE (PORCINE 5500 MW)

Structure of DILINOLEIC ACID/BUTANEDIOL COPOLYMER

Polymer

DILINOLEIC ACID/BUTANEDIOL COPOLYMER

Structure of PEG-55 PROPYLENE GLYCOL OLEATE

Polymer

PEG-55 PROPYLENE GLYCOL OLEATE

Structure of POLYGLYCERYL-6 RICINOLEATE

Polymer

POLYGLYCERYL-6 RICINOLEATE

Showing 161 - 170 of 343 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1